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H
igh long-term survival rates
(more than 90%) have been re-
ported for dental implants and
implant-supported prosthetic restora-
tions aimed at functional and esthetical
rehabilitation.1–4 Despite successful os-
seointegration and function over many
years, dental implants are susceptible to
inflammatory periimplant diseases (ie,
mucositis or periimplantitis) affecting
the supporting tissues and leading to
partial or even total loss of osseointe-
gration.5 Both mucositis and periim-
plantitis are defined as inflammatory
lesions of the mucosa, which in muco-
sitis is strictly limited to the surround-
ing mucosa, while in periimplantitis,
the mucosal inflammation is associated
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Background: The data on the
importance of soft-tissue management
during surgical treatment of periimplan-
titis are still limited, and no clinical
recommendations are yet available.
Aim: To give an overview on the
rationale for periimplant soft-tissue aug-
mentation procedures in the light of
potential benefits/risks of the presence/
absence of keratinized/attached mucosa
(KAM) providing recommendations for
the clinician.
Results: The available evidence in-
dicates that the presence of KAM favors
periimplant tissue health evidenced by
improved bleeding scores and facilitation of
self-performed plaque removal, less mucosal
recessions, and more stable marginal bone
levels over time. Therefore, the rationales to
augment KAM are (a) to optimize the
possibility for performing an adequate level
of oral hygiene, (b) to help maintaining
periimplant soft-tissue health and stability,
and (c) to improve esthetics. Various techni-
ques with autogenous or xenogeneic mem-
branes have been described so far for KAM
augmentation. Additional soft-tissue grafting
in conjunction with a combined regenerative
and resective surgical procedure seems to be
effective in treating and controlling advanced
periimplantitis lesions and improving or
maintaining the esthetic outcomes.
Conclusions: The limited available
data seem to indicate that the best out-
come to improve the width of KAM, and
the bleeding and plaque scores, as well
as to maintain the periimplant marginal
bone level is the use of an apically
positioned flap combined with a free
gingival graft in nondiseased periimplant
sites. However, at present, it is unknown:
(a) to what extent soft-tissue grafting may
additionally improve the outcomes after
surgical (resective or regenerative) treat-
ment of periimplantitis compared with
the same approaches without soft-tissue
grafting, and (b) if considered, when
should soft-tissue grafting be performed
(eg, before or during surgical treatment
of periimplantitis).
Clinical Recommendations:
Both soft-tissue resective and regenerative
approaches may lead to successful out-
comes depending on the clinical indica-
tion and defect location. However, the
selection of one or another surgical
approach should be based on defect type
(eg, intrabony and suprabony) and loca-
tion (esthetic or nonesthetic areas). The
presence of an adequate width and thick-
ness of KAM may facilitate soft-tissue
(flap) management. In patients with a thin
phenotype or lack of an adequate width of
KAM, soft-tissue grafting may improve
the clinical outcomes. (Implant Dent
2019;28:210–216)
Key Words: periimplantitis, soft-
tissue management, soft-tissue graft-
ing, attached mucosa, resective
surgery, regenerative surgery
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with loss of supporting bone and
osseointegration.5,6 Prevalence rates
from a recent systematic review were
reported for periimplant mucositis at
43% (range: 19%–65%) and for periim-
plantitis at 22% (range: 1%–47%).7
Bacterial pathogens (ie, periodon-
tal pathogens with a similar composi-
tion of the microbiota in chronic
periodontitis) represent the primary
etiological factor for periimplant dis-
eases.8,9 In addition, the individual
local inflammatory response and the
misbalance of the host-parasite interac-
tion are mandatory for the initiation of
inflammatory periimplant diseases.10
Various risk factors have been identi-
fied to favor periimplant tissue destruc-
tion and play a role in the pathogenesis
including history of periodontitis, poor
oral hygiene cigarette smoking, diabe-
tes with poor metabolic control, genetic
traits, alcohol consumption, and
implant surface.6,11,12 The lack of Ker-
atinized/attached mucosa (KAM) as a
possible risk factor for periimplant dis-
ease has been also investigated.12 None-
theless, an early identification of risk
factors, assurance of an optimal self-
performed oral hygiene, and therapeuti-
cal strategies to minimize the develop-
ment of periimplant diseases have been
suggested to maintain long-term dental
implants.13
Based on the available evidence for
the treatment of established periimplanti-
tis lesions, no specific recommendations
with predictable treatment outcomes can
be made.14,15 Since nonsurgical treat-
ment of periimplantitis shows only lim-
ited efficacy,10 the goal of surgical
therapy is to improve the cleansability
of the implant surface on one side, and
on the other side to modify the anatomy
of soft and hard periimplant tissues to
sustain reosseointegration and long-term
maintenance of dental implants.10
Conflicting data can be found regard-
ing the influence of the amount of periim-
plant KAMon periimplant health, and no
strong evidence can be found indicating
the benefits or risks for its presence or
absence.16–18 However, earlier findings
from a preclinical study have demon-
strated that the absence of KAM around
dental endosseous implants increases the
susceptibility of the periimplant region to
plaque-induced tissue destruction.19
Although some authors have re-
ported on positive effects on periim-
plant healthwhenKAMwas present,20–
22 others sustain that its presence may
not influence implant survival.16 More-
over, patient-centered outcomes have
been little investigated in this respect,
and this is an issue that has to be con-
sidered that pain caused during brush-
ing in situations with limited or no
KAMat implantsmay hamper adequate
cleaning and thus represent a risk factor
for periimplant inflammation. Analyz-
ing the evidence for performing various
types of periodontal plastic procedures
to gainKAMor increase its thickness to
achieve periimplant health and prevent
periimplant diseases, there is a lack in
strong evidence and clinical recommen-
dations, and no unanimous consensus
exists. Moreover, no clear indications
for handling periimplant soft tissues
exist.
Considering that there are no clear
guidelines for the surgical treatment of
periimplantitis and that the soft-tissue
anatomy seems to play a major role in
the development of periimplant dis-
eases, the aim of the this article was to
review the current surgical treatment
options to increase KAM at healthy and
diseased implants and their efficacy for
the prevention and treatment of periim-
plant diseases.
ROLE OF KERATINIZED ATTACHED
MUCOSA IN MAINTAINING
PERIIMPLANT TISSUE HEALTH
It has been generally accepted that
assessment of periimplant health is
based on the clinical parameters bleed-
ing on probing (BOP) and gingival
bleeding indices, probing depths
(PDs), and marginal periimplant bone
level.11,23,24 Therefore, changes in
the biological periimplant tissues to
establish the status of periimplant
health are determined using these
parameters.25,26
The presence and thickness of KAM
as related to the health and long-term
stability of periimplant tissues have been
controversially reported in the litera-
ture.11,18,19,27–36
On one hand, some clinical studies
showed no correlation between the pres-
ence of an “adequate” band (ie,$2 mm)
ofKAMand implant stability as assessed
by periimplant bone level or probing pa-
rameters (ie, PDs).1,20,28,31,35,37–40 More-
over, results from animal studies
sustain the idea that the presence of an
“adequate” width of KAM does not sig-
nificantly influence periimplant tissue
conditions.34
On the other hand, various clinical
studies have suggested that the lack of an
adequate width (#2 mm) of KAM is
related to a higher risk of periimplant
inflammation and loss of soft and hard
tissue.19,29,36 Some authors reported sig-
nificant associations between a periim-
plant KAM width of less than 2 mm
and higher bleeding scores,40–44 higher
plaque accumulation,37–39,41,43,45,46 and
more mucosal inflammation37–39,41,46
compared to sites with adequate KAM
width ($2 mm). Despite these findings,
results from a retrospective study re-
ported low incidence rates of periimplant
diseases in patients in maintenance ther-
apy irrespective of the width of KAM.47
The authors suggest that maintaining an
optimal level of plaque control is manda-
tory for assuring periimplant tissue health
rather than the presence of an adequate
width of KAM.
However, at present, it is generally
accepted that the presence of an adequate
width of KAM around dental implants is
associated with a better soft- and hard-
tissue stability38 and less plaque accumu-
lation, less soft-tissue recession, and
lower incidence of periimplant mucosi-
tis. Confirming these facts, Roccuzzo
et al48 have evaluated the clinical condi-
tions around dental implants placed in
the posterior mandible of healthy or
moderately periodontally compromised
patients in relation to the presence or
absence of KAM. The absence of
KAMwas associated with higher plaque
accumulation, greater soft-tissue reces-
sion (REC), and a higher number of sites
that required additional surgical and/or
antibiotic treatment indicating that im-
plants that are not surrounded by KAM
are more prone to plaque accumulation
and development of soft-tissue recession
despite adequate oral hygiene and sup-
portive periodontal therapy.
On the other hand, findings from a
retrospective study failed to reveal an
increased incidence of periimplant in-
fections independent of the absence or
presence of KAM when the patients
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were enrolled in a maintenance
program.47
However, taken together, most of
the available evidence indicates that the
lack of an adequate width of KAM
around dental implants is associated
with more plaque accumulation, inflam-
mation, soft-tissue recession, and attach-
ment loss.17,42,48–51
A very recent systematic review
has evaluated the effects of soft-tissue
augmentation procedures on periim-
plant health or disease in partially and
fully edentulous patients.22
The soft-tissue grafting procedures
consisted of either increase of kerati-
nized tissue width or an increase of the
thickness of the periimplant mucosa.
The findings indicated that soft-tissue
grafting by means of autogenous grafts
may favor periimplant health through
gain of KAM, improved bleeding
scores, and less marginal bone loss. In
the esthetic zone, the use of autogenous
connective tissue grafts (CTGs) re-
sulted in an increase in the mucosal
thickness around implants and was
associated with statistically signifi-
cantly less marginal bone loss over
time. However, the data failed to reveal
statistically significant changes in terms
ofBOP, PDs, or plaque scores at grafted
sites compared to sites without grafting.
Nonetheless, taken together, based on
the available evidence, it is generally
accepted that soft-tissue augmentation
procedures are beneficial to establish
and maintain periimplant health.
Regarding the periimplant mucosal
thickness, findings of preclinical and
clinical studies suggested a threshold
value of 2-mm mucosal thickness for
establishing natural periimplant mucosal
appearances and minimal soft-tissue dis-
coloration at implant-supportedprosthetic
reconstructions.52–55 In addition, ade-
quate mucosal thickness has been shown
to decrease the risk of recessions in imme-
diate placement protocols or in specific
anatomical situations (ie, minimal or no
facial bonywall, orofacial implantmalpo-
sitions, and various angles of the implant
fixtures).44,56,57
Despite the fact that several system-
atic reviews indicate that a periimplant
KAM width of less than 2 mm may be
correlated with higher plaque levels
and periimplant tissue inflammation,
soft-tissue recession, and attachment
loss,17,18,21,42,51 there are still insuffi-
cient data on the influence and thickness
of periimplant KAM and the long-term
survival and success rates of dental
implants.58
According to a recent systematic
review, no specific soft-tissue width and
thickness can be defined to maintain
periimplant health.59 However, results
from a very recent systematic review
and meta-analysis indicate that soft-
tissue grafting procedures may lead to
favorable periimplant health conditions
evidenced by improved bleeding indices
and higher marginal bone levels.22
Taken together, the goal of aug-
menting periimplant mucosa is to
assure long-term tissue stability by
optimizing the possibility for perform-
ing and maintaining adequate periim-
plant plaque control in patients with
inadequate width (,2 mm) and thick-
ness (,2mm) of nonmobile mucosa; to
facilitate flap handling and wound sta-
bility; to support maintaining periim-
plant soft-tissue health and stability;
and to improve esthetics.
PERIIMPLANT SOFT-TISSUE
AUGMENTATION PROCEDURES
Periimplant soft-tissue augmenta-
tion procedures may be helpful to ensure
long-term biological, functional, and
esthetic outcomes at osseointegrated den-
tal implants. These may be indicated to
gain KAM, to augment soft-tissue vol-
umeor tocover recessions.44,54,60–62Var-
ious surgical techniques combined with
autogenous connective or free gingival
grafts (FGGs) or with collagen mem-
branes have been investigated for gain
in KAM or for thickness augmentation.
Statistically significantly better out-
comes for gain in keratinized tissue
width, for lower bleeding (BOP, gingival
index) and plaque scores, as well as less
recession and marginal bone changes
were observed in patients treated with
the apically positioned flap in conjunc-
tion with an FGG as compared to control
groups where no grafting was per-
formed.48,63 When comparing outcomes
between theFGGandanacellular dermal
matrix (ADM) allograft, statistically sig-
nificantly greater gain inKAM, less post-
operative relapse, lower plaque, and
gingival bleeding scores were obtained
after 6 months in patients with less than
1.5-mm KAM treated with FGG com-
pared to ADM.64 However, when a
xenogeneic collagen matrix or a CTG
was used in subjects with less than 1-
mmKAM,no statistically significant dif-
ferences could be seen after 6 months
between the treatment groups with
respect to gain in the width of KAM or
the esthetic results.61 An important
aspect in these studies is that, with the
exception of Basegmez et al who
included also sites with mucositis, only
healthy implants were treated.48,61,63
Regarding the increase of KAM
thickness, most studies have investi-
gated the use of subepithelial CTGs at
the time of implant placement65–67 or in
the healing phase as compared to con-
trol groups with no soft-tissue augmen-
tation procedures.68–70 Most studies
obtained after a minimal follow-up of
1 year significant better outcomes for
esthetical indexes, lower recession
rates,65–67,69,70 lower PD values,65,66,68
and less bone level changes.66,67 How-
ever, Bienz et al reported after 5 years of
follow-up only minimal linear and vol-
umetric mucosal changes in subjects
where CTG was performed concomi-
tant with guided bone regeneration (test
group), and no statistically significant
differences were seen between the test
and the control group (no CTG aug-
mentation). Augmenting periimplant
soft-tissue volume with CTG had no
significant influence on bleeding66,68–70
and plaque scores.65,66,68–70
A recent systematic review and
meta-analysis that evaluated the effec-
tiveness of periimplant soft-tissue graft-
ing and their effect on periimplant
health showed statistically significant
outcomes in cases where grafting pro-
cedures had been performed for gingi-
val indexes (weighted mean difference
[WMD] ¼ 0.86 mm).22 Moreover,
the use of apically positioned flap in
conjunction with autogenous grafts as
compared to control subjects with no
grafting or grafting with collagen
matrix led to more stable final marginal
bone levels (WMD ¼ −0.175 mm). In
this review, the meta-analysis showed
that volumetric soft-tissue augmenta-
tion procedures with CTG did not sta-
tistically significantly affect bleeding
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indices; however, significantly less
marginal bone loss occurred when aug-
mentation procedures were performed
(WMD¼ 0.110 mm).22 Based on these
results, a recent consensus report rec-
ommends soft-tissue augmentation pro-
cedures to promote periimplant
health.71
Taken together, various techniques
such as resective, apical repositioned
flaps combined with the use of autoge-
nous grafts (FGG and CTG) or
xenogenic/allogenic materials have
been shown to be successful for non-
mobile KAM augmentation. Autoge-
nous materials seem to be superior to
other substitute materials.
SOFT-TISSUE MANAGEMENT
IN PERIIMPLANTITIS
Basically, 2 modalities for soft
tissue management in conjunction with
surgical treatment of periimplantitis
have been described in the literature
so far: a resective one, more indicated
in situations with no esthetical de-
mands,10,72,73 and a tissue preservation
approach when regeneration of the de-
fects is aimed.10,74–76 The resective
approach aims to reduce the periimplant
pockets and to enhance the self-
performed oral hygiene77; with this
technique, the collar of the affected tis-
sues is removed, and the flap is reposi-
tioned apically.72 However, it has to be
kept in mind that this approach is asso-
ciated with a substantial apical dis-
placement of the gingival margin and
loss of soft tissue. Therefore, this
approach is contraindicated for estheti-
cally demanding areas and more suit-
able for posterior zones.
When regenerative surgery is
considered, a recession of the mucosa
should be as much as possible avoided to
support 3-dimensionally the tissue di-
mensions and the reosseointegration by
means of various types of bone grafts and
membranes.10 Such a technique avoids
“per se” any removal of the periimplant
mucosa, and various grafts (ie, autolo-
gous bone and bone substitutes) com-
bined with resorbable or
nonbioresorbable membranes are used
to fill/cover the intrabony compo-
nents.74,75,78 However, it needs to be
pointedout that although thedefectswere
filled and no removal of the inflamed tis-
sue collar was performed, some mucosal
recession has still occurred despite the
favorable clinical outcomes reported for
BOP, PD, and Clinical attachment level
(CAL).75,79,80
Weak evidence, based on a single
case report and a case series, is available
on the use of soft-tissue augmentation
using either a xenogenic collagen matrix
or CTG in conjunction with a combined
regenerative and resective surgical treat-
ment of periimplantitis.81 In those cases,
favorable clinical results (BOP, PD, and
CAL) have been obtained after treating
advanced periimplantitis defects with
combined implantoplasty, augmentation
of the intrabony defects with a natural
bonemineral, and soft-tissuegrafting.81,82
One case report described the com-
bined surgical therapy of an advanced
periimplantitis in a case with thin
mucosal tissue.81 The treatment con-
sisted of access flap surgery, implanto-
plasty at buccally and supracrestally
exposed implant parts, and augmenta-
tion of the intrabony component by
means of a natural bone mineral and a
native collagenmembrane after implant
surface decontamination. Concomi-
tantly, soft-tissue volume augmentation
by means of a collagen matrix was also
performed. At 36 months after therapy,
the clinical evaluation revealed clinical
stability evidenced by substantial re-
ductions in BOP and PD accompanied
by limited soft-tissue recessions.
Furthermore, a regain inmucosal height
and KAMwas also noted at 24 months.
The authors have suggested the com-
bined surgical procedure as an effective
means in treating and controlling peri-
implantitis defects without compromis-
ing the overall esthetic outcomes.
The second report has evaluated the
outcomes in 10 patients with a total of 13
implants exhibiting combined suprabony
and intrabony defects after treatment
using accessflap surgery, implantoplasty
at buccally and supracrestally exposed
implant parts, and augmentation of the
intrabony components by means of a
natural bone mineral and a native colla-
gen membrane after surface decontami-
nation. In addition, a subepithelial CTG
was harvested from the palate and adap-
ted over the wound area to support
transmucosal healing.82 The clinical
outcomes at 6 months have shown that
the combined surgical procedure was
associated with statistically significant
improvements in terms of BOP and PD
reductions and gains of clinical attach-
ment levels. In addition, a slight increase
in mean mucosal height, attributed to the
use of CTG, was measured at the buccal
aspects.
It has, however, to be pointed out
that, on one hand, the clinical outcomes
obtained in the aforementioned clinical
reports in terms of PD, BOP, and CAL
were comparable with those where only
bony reconstruction (eg, without soft-
tissue grafting) of the periimplantitis
defect was performed by means of
various types of grafting materials
(nanocrystalline hydroxyapatite, natural
bone mineral and collagen membrane,
algae-derived xenograft, and resorbable
synthetic membrane)75,79,80 or with an
open flap debridement, implant decon-
tamination, and use of systemic antibi-
otics.83 On the other hand, in the
reported studies (eg, without soft-tissue
grafting), neither improvements nor an
increase in the mucosal recession at the
treated defects were observed.
It may thus be anticipated that
additional soft-tissue grafting in con-
junction with a combined surgical pro-
cedure may be effective in treating and
controlling advanced periimplantitis le-
sions by improving or maintaining the
esthetic outcomes. However, despite
the lack of scientific evidence, the
increase of nonmobile KAM width
and thickness before periimplant surgi-
cal approaches seems reasonable. In
addition, clinicians should consider
the removal/decrease ofmuscular activ-
ity and frenula pull at affected sites
before or during the surgical treatment
of periimplantitis to facilitate the surgi-
cal approach and clinical outcomes.
CONCLUSIONS
The limited available data indicate
that the best outcome to improve the
width of KAM, and the bleeding and
plaque scores, as well as to sustain the
periimplant marginal bone level is the
use of an apically positioned flap com-
bined with an FGG in nondiseased
periimplant sites. However, at present,
it is unknown: (a) to what extent
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soft-tissue grafting may additionally
improve the outcomes after surgical
(resective or regenerative) treatment of
periimplantitis compared with the same
approaches without soft-tissue grafting,
and (b) if considered, when should soft-
tissue grafting be performed (eg, before
or during surgical treatment of
periimplantitis).
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